Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones

Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones

US Patent 6897212 · Granted May 24, 2005

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CCL2 inhibitors2024
CCL5 inhibitors2023
CCL5 inhibitors2022
Compositions and methods for treating skin conditions, acne form lesions, and ac2022
CCL5 inhibitors2022
CCL2 inhibitors2021
CCL5 inhibitors2021
Methods and compositions for acid phosphatase-1 gene inhibition2011
Association between the acid phosphatase (ACP1) gene and Alzheimer's disease2005
Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major dep2004
Polymorphisms in the PNMT gene2003
Association of the serotonin transport (HTT) gene with cardiovascular disease an2003